Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non …
C Seree-Aphinan, P Rattanakaemakorn… - Vaccines, 2024 - mdpi.com
The intradermal route has emerged as a dose-sparing alternative during the coronavirus
disease 2019 (COVID-19) pandemic. Despite its efficacy in healthy populations, its …
disease 2019 (COVID-19) pandemic. Despite its efficacy in healthy populations, its …